MGLL and cancer: The selective MAGL inhibitor KML29 only showed antiproliferative activity against B16-F10 and HT-29 cells, while compounds 23, 82, and 93 identified as potential MAGL inhibitors in our study also showed antiproliferative activities against other cancer cells, including A431, H1975, OVCAR-3, and A549.